FDA Inspection
Fertility Center of Southern CaliforniaFertility Center of Southern California – FDA Inspection, Mar 14, 2025
Record Details
This FDA Inspection record concerns Fertility Center of Southern California, with an inspection on March 14, 2025, issued by the Los Angeles District Office, covering biologics.
View Company Profile
ID · c315534f-0124-44bd-a1ad-1301665aee1d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1263784
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.50(a)Determination based on screening and testing
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Fertility Center of Southern California
4| Date | Classification | Office | Project area |
|---|---|---|---|
| October 6, 2022 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| October 12, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 7, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 5, 2011 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Fertility Center of Southern California
- FDA Inspection 1181392 - 2022-10-06
- FDA Inspection 1029769 - 2017-10-12
- FDA Inspection 855743 - 2013-11-07
- FDA Inspection 722453 - 2011-05-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.